Keratoconus
VIDEO: Corneal tissue addition keratoplasty offers advantages for keratoconus treatment
NEW YORK — In this Healio Video Perspective from OSN New York, Mitchell A. Jackson, MD, of Jacksoneye in Lake Villa, Illinois, discusses the benefits of corneal tissue addition keratoplasty for patients with keratoconus.
VIDEO: ‘Remember our important role’ for World Keratoconus Day
INDIANAPOLIS — According to the National Keratoconus Foundation, Nov. 10 is World Keratoconus Day, which is dedicated to raising awareness about the condition and advocating for those affected by it.
VIDEO: OCT elastography study reveals effect of femto-CAIRS on corneal biomechanics
BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Emilio Torres-Netto, MD, PhD, discusses biomechanical changes produced by the implantation of femto-CAIRS.
VIDEO: PACE cross-linking improves vision without removing tissue
BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Farhad Hafezi, MD, PhD, gives an update on PTK-assisted customized epi-on cross-linking, or PACE.
VIDEO: Study shows low risk for complications from corneal cross-linking
CHICAGO — In this Healio Video Perspective from the AAO meeting, Zeba A. Syed, MD, discusses results of a study conducted at Wills Eye Hospital that examined corneal cross-linking complications in more than 900 patients.
A plea for universal keratoconus screening for all pediatric patients
The earlier we detect keratoconus, the better our chances of preserving functional vision by stabilizing the cornea with cross-linking treatment.
VIDEO: Patients older than 40 years still at risk for keratoconus progression
CHICAGO — In this Healio Video Perspective from the AAO meeting, William B. Trattler, MD, discusses a study that evaluated age and keratoconus progression.
BLOG: What to know about post-refractive ectasia
Post-refractive ectasia occurs very rarely, in only about one out of every 10,000 cases of refractive surgery, or 0.09% of LASIK procedures, 0.02% of PRK procedures and 0.01% of SMILE procedures, according to Moshirfar and colleagues.
Epioxa meets primary efficacy endpoint in second phase 3 confirmatory trial
Glaukos announced that Epioxa, its next-generation corneal cross-linking iLink therapy for the treatment of keratoconus, demonstrated statistically significant improvement from baseline vs. placebo in maximum corneal curvature at 12 months.
Second-generation ELZA-sub400 CXL protocol shows promise in treating ultrathin corneas
BARCELONA, Spain — One-year results with the second-generation ELZA-sub400 protocol for corneal cross-linking showed efficacy in halting keratoconus progression in ultrathin corneas, according to a study presented here.